Is it a good company at a reasonable price? Simply Wall Street thinks this stock is underpriced. The Analysts Recommendations for the 12 month stock price imply that the stock is underpriced. That would imply that the stock price is relatively cheap. I sort of doubt that as the stock is just off an historical high. I currently would not be tempted to buy because it is really not a dividend stock with a dividend yield of just 0.12%. My testing is implying that the stock price is on the expensive side.
I do not own this stock of AtkinsRealis Group Inc (TSX-ATRL, OTC-SNCAF), but I used to. This stock was one from Mike Higgs' list of dividend growth stocks as SNC-Lavalin Group Inc. By 2008 this stock had grown so much it was too high a percentage of my portfolio so I sold 1/3 of my stock. I sold all my stock in SNC-Lavalin (TSX-SNC, OTC-SNCAF) in 2019. I had given up hope that there will be any sort of resolution for this company anytime soon. I live off my dividends and they have cut the dividends twice that year.
When I was updating my spreadsheet, I noticed what I would have gotten on this stock if I had continued to hold it to today. My capital gains would have been roughly the same at around 19% per year. My dividend income would have been a lot lower.
If you had invested in this company in December 2014, for $1,019.13 you would have bought 23 shares at $44.31 per share. In December 2024, after 10 years you would have received $113.16 in dividends. The stock would be worth $1,753.98. Your total return would have been $1,867.14. This would be a total return of 6.59% per year with 5.58% from capital gain and 1.01% from dividends.
Cost | Tot. Cost | Shares | Years | Dividends | Stock Val | Tot Ret |
---|---|---|---|---|---|---|
$44.31 | $1,019.13 | 23 | 10 | $113.16 | $1,753.98 | $1,867.14 |
The current dividend yield is low with dividend growth negative. The current dividend yield is low (below 2%) at 0.12%. Hardly a dividend at all. The 5, 10 and historical dividend yields are also low at 0.27%, 0.53% and 1.40%. The dividends have declined by 20% per year over the past 5 years. This is because of a dividend cut of 93% in 2019. Analysts last year thought there would be a dividend increase in 2026, now they think it will be 2027.
The Dividend Payout Ratios (DPR) are good. The DPR for 2024 for Earnings per Share (EPS) is good at 5% with 5 year coverage at 21%. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is good at 4% with 5 year coverage at 11%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 2% with 5 year coverage at 5%. The DPR for 2024 for Free Cash Flow (FCF) is good at 3% with 5 year coverage at 3%.
Item | Cur | 5 Years |
---|---|---|
EPS | 4.94% | 21.16% |
AEPS | 4.47% | 10.55% |
CFPS | 1.95% | 5.17% |
FCF | 3.26% | 2.97% |
Debt Ratios are fine, but Liquidity Ratio could be improved. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.13 and currently at 0.14. The Liquidity Ratio for 2024 is too low at 1.02 and 1.02 currently. If you added in Cash Flow after dividends, the ratios are still low at 1.13 and currently at 1.13. Even if I add back the current portion of the debt the Liquidity Ratio is too low at 1.13. The current portion of the debt is small. I prefer the Liquidity Ratio to be at 1.50 or higher. The Debt Ratio for 2024 is good at 1.51 and 1.51 currently. The Leverage and Debt/Equity Ratios for 2024 are fine at 2.98 and 1.98 and currently at 2.98 and 1.98.
Type | Year End | Ratio Curr |
---|---|---|
Lg Term R | 0.13 | 0.14 |
Intang/GW | 0.28 | 0.32 |
Liquidity | 1.02 | 1.02 |
Liq. + CF | 1.13 | 1.12 |
Liq. +CF +D | 1.13 | 1.13 |
Debt Ratio | 1.51 | 1.51 |
Leverage | 2.98 | 2.98 |
D/E Ratio | 1.98 | 1.98 |
The Total Return per year is shown below for years of 5 to 36 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
From | Years | Div. Gth | Tot Ret | Cap Gain | Div. |
---|---|---|---|---|---|
2019 | 5 | -19.73% | 20.72% | 20.55% | 0.17% |
2014 | 10 | -22.00% | 6.59% | 5.58% | 1.01% |
2009 | 15 | -12.57% | 3.37% | 2.33% | 1.04% |
2004 | 20 | -4.06% | 8.83% | 7.10% | 1.73% |
1999 | 25 | 0.00% | 16.27% | 12.93% | 3.35% |
1994 | 30 | 2.63% | 14.81% | 12.07% | 2.74% |
1989 | 35 | 6.89% | 14.99% | 12.31% | 2.68% |
1988 | 36 | 4.65% | 20.03% | 15.40% | 4.64% |
The 5-year low, median, and high median Price/Earnings per Share Ratios are 22.89, 37.18 and 48.47. The corresponding 10 year ratios are 18.36, 22.53 and 27.08. The corresponding historical ratios are 14.63, 21.05 and 25.16. The current P/E Ratio is 25.05 based on a stock price of $68.22 and EPS estimate for 2025 of $2.72. This ratio is between the median and high ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.
I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 23.45, 33.65 and 43.79. The corresponding 10 year ratios are 19.51, 28.21 and 36.73. The corresponding historical ratios are 15.98, 21.72 and 27.76. The current ratio is 23.61 based on a stock price of $68.22 and AEPS estimate for 2025 of $2.89. This ratio is low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I get a Graham Price of $37.46. The 10-year low, median, and high median Price/Graham Price Ratios are 1.13, 1.70 and 2.11. The current ratio is 1.82 based on a stock price of $68.22. This ratio is between the median and high ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.
I get a 10-year median Price/Book Value per Share Ratio of 1.82. The current ratio is 3.16 based on a stock price of $68.22, Book Value of $3,775M and Book Value per Share of $21.58. The current ratio is 74% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.
I also have a Book Value per Share estimate for 2025 of $23.00. This implies a ratio of 2.97 based on a stock price of $68.22 and Book Value of $4,021M. This ratio is 63% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.
I get a 10-year median Price/Cash Flow per Share Ratio of 29.01. The current ratio is 23.61 based on a Cash Flow per Share estimate for 2025 of $2.89, Cash Flow of $505M and a stock price of $68.22. The current ratio is 19% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I get an historical median dividend yield of 1.40%. The current ratio is 0.12% based on a stock price of $68.22 and dividends of $0.08. The current dividend yield is 92% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This is not a good test because dividends were cut in 2018 and then have been flat since 2019. However, dividends cuts and flat dividends are also not good.
I get a 10 year median dividend yield of 0.53%. The current ratio is 0.12% based on a stock price of $68.22 and dividends of $0.08. The current dividend yield is 78% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This is not a good test because dividends were cut in 2018 and then have been flat since 2019. However, dividends cuts and flat dividends are also not good.
The 10-year median Price/Sales (Revenue) Ratio is 0.71. The current P/S Ratio is 1.14 based on Revenue estimate for 2025 of $10,484M, Revenue per Share of $59.96 and a stock price of $68.22. The current ratio is 59% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.
Results of stock price testing is that the stock price is probably expensive. The dividend yield testing is saying this, but these are not good tests. The P/S Ratio testing however is also saying that the stock price is relatively expensive. The rest of the testing ranges from reasonable to expensive. The P/AEPS Ratio test is a good one and it says that the stock price is reasonable and below the median. The P/B Ratio test is also a good one and it says that the stock price is relatively expensive.
When I look at analysts’ recommendations, I find Strong Buy (6), Buy (7) and Hold (1). The consensus is a Strong Buy. The 12 month stock price consensus is $91.29 with a high of $105.00 and low of $74.00. The 12 month stock price consensus implies a total return of 33.93% with 33.82% from capital gains and 0.12% from dividends based on a current stock price of $68.22.
There are a number of analysts’ recommendations on Stock Chase for 2024 and they are all buys. There are no entries for 2025. Christopher Liew on Motley Fool says to buy for stability and growth. Amy Legate-Wolfe on Motley Fool says buy as a long term investment. The company put out a Press Release about their fourth quarter of 2024.
Simply Wall Street via Yahoo Finance reviews this stock and thinks it is underpriced. Simply Wall Street has no warnings out on this stock.
Based in Montreal, AtkinsRéalis is a fully integrated professional services and project management firm that offers a wide range of services, including financing, consulting, engineering and construction, procurement, and operations and maintenance. The firm serves clients in the infrastructure, nuclear, and engineering design and project management industries. Its web site is here AtkinsRealis Group Inc.
The last stock I wrote about was about was Barclays PLC ADR (LSE-BARC, NYSE-BCS) ... learn more. The next stock I will write about will be Fortis Inc (TSX-FTS, OTC-FRTSF) ... learn more on Friday, May 2, 2025 around 5 pm. Tomorrow on my other blog I will write about Hand Holding.... learn more on Thursday, May 1, 2025 around 5 pm.
This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.
See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.